Nasdaq:US$14.77 (+0.34) | HKEX:HK$23.26 (+0.38) | AIM:£2.18 (-0.01)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 肿瘤学 / 免疫学 | 2006-07-04

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate